1. Home
  2. CYTK vs CVLT Comparison

CYTK vs CVLT Comparison

Compare CYTK & CVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • CVLT
  • Stock Information
  • Founded
  • CYTK 1997
  • CVLT 1996
  • Country
  • CYTK United States
  • CVLT United States
  • Employees
  • CYTK N/A
  • CVLT N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • CVLT Computer Software: Prepackaged Software
  • Sector
  • CYTK Health Care
  • CVLT Technology
  • Exchange
  • CYTK Nasdaq
  • CVLT Nasdaq
  • Market Cap
  • CYTK 6.0B
  • CVLT 5.9B
  • IPO Year
  • CYTK 2004
  • CVLT 2006
  • Fundamental
  • Price
  • CYTK $48.87
  • CVLT $158.73
  • Analyst Decision
  • CYTK Buy
  • CVLT Buy
  • Analyst Count
  • CYTK 16
  • CVLT 8
  • Target Price
  • CYTK $84.07
  • CVLT $155.43
  • AVG Volume (30 Days)
  • CYTK 1.1M
  • CVLT 289.5K
  • Earning Date
  • CYTK 11-06-2024
  • CVLT 01-28-2025
  • Dividend Yield
  • CYTK N/A
  • CVLT N/A
  • EPS Growth
  • CYTK N/A
  • CVLT N/A
  • EPS
  • CYTK N/A
  • CVLT 3.94
  • Revenue
  • CYTK $3,219,000.00
  • CVLT $898,050,000.00
  • Revenue This Year
  • CYTK N/A
  • CVLT $16.12
  • Revenue Next Year
  • CYTK $795.25
  • CVLT $11.54
  • P/E Ratio
  • CYTK N/A
  • CVLT $40.31
  • Revenue Growth
  • CYTK N/A
  • CVLT 12.58
  • 52 Week Low
  • CYTK $43.21
  • CVLT $73.33
  • 52 Week High
  • CYTK $110.25
  • CVLT $178.72
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 44.62
  • CVLT 38.20
  • Support Level
  • CYTK $45.66
  • CVLT $157.58
  • Resistance Level
  • CYTK $49.40
  • CVLT $176.67
  • Average True Range (ATR)
  • CYTK 1.71
  • CVLT 4.84
  • MACD
  • CYTK -0.20
  • CVLT -2.35
  • Stochastic Oscillator
  • CYTK 50.79
  • CVLT 14.15

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About CVLT Commvault Systems Inc.

CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Commvault Complete Backup and Recovery, HyperScale, Hedvig, and Metallic. The company operates in the United States and exports to many other countries.

Share on Social Networks: